VTv Therapeutics Highlights Progress on Diabetes Treatment

TipRanksJan 13 09:01 ET

VTv Therapeutics Analyst Ratings

BenzingaDec 9, 2024 11:57 ET · Ratings

Express News | Cantex Pharmaceuticals Receives FDA Orphan Drug Designation for Azeliragon for the Treatment of Brain Metastasis From Breast Cancer

ReutersDec 9, 2024 07:33 ET

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER

PR NewswireDec 9, 2024 07:33 ET

A. G. P. Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $35

Moomoo NewsDec 9, 2024 07:31 ET · Ratings

Express News | VTv Therapeutics Inc : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $35

ReutersDec 9, 2024 07:19 ET